首页> 外文期刊>Global spine journal. >Usefulness of Tokuhashi Score in Survival Prediction of Patients Operated for Vertebral Metastatic Disease
【24h】

Usefulness of Tokuhashi Score in Survival Prediction of Patients Operated for Vertebral Metastatic Disease

机译:德桥评分在椎体转移性疾病患者生存预测中的作用

获取原文
           

摘要

Study Design: Retrospective study. Objective: Spinal metastasis can produce pain, deformity, neurological compromise and can decrease life expectancy. Surgical management is usually indicated for pain control, neurological decompression, and to avoid deformity progression. Tokuhashi et al created a scoring system to estimate survival and stratify surgical treatment based on established parameters. Our objective was to evaluate the usefulness of Tokuhashi scoring (TS) system by comparing the predicted and real survival times and analyze the survival time according to the type of tumor. Methods: From 2004 to 2014, 105 patients with vertebral metastasis who underwent surgical treatment were enrolled and retrospectively analyzed. Preoperative TS was performed in all cases. Patients were classified into 3 groups according to TS; group 1 (TS 0-8), group 2 (TS 9-11), and group 3 (TS 12-15). Patients’ average age was 61.5 years, main primary tumor site were as follows: kidney (23%), lung (19%), and breast (18%). Results: The Tokuhashi general concordance was 67.6%. Per group concordance was as follows: group 1 80%, in group 2, only 33% of concordance was observed. In group 3, 100% of concordance was observed. In group 2, the most common primary sites were breast and kidney and the mean survival was 20 and 22.3 months, respectively, both longer than that expected for this group. Conclusions: Tokuhashi concordance was acceptable in our study, particularly in lower and higher scores. The lesser concordance observed in group 2 (33.3%) was observed in almost all tumors. For our practice, TS constitutes an acceptable tool to define survival, particularly in lower and higher scores.
机译:研究设计:回顾性研究。目的:脊柱转移瘤可引起疼痛,畸形,神经系统损害,并可能缩短预期寿命。通常需要进行手术管理以控制疼痛,神经系统减压并避免畸形进展。 Tokuhashi等人创建了一个评分系统,以评估生存率并根据已建立的参数对手术治疗进行分层。我们的目标是通过比较预测生存时间和实际生存时间并根据肿瘤类型分析生存时间来评估德桥评分(TS)系统的有效性。方法:回顾性分析2004年至2014年接受手术治疗的105例椎骨转移患者。在所有情况下均进行术前TS。根据TS将患者分为3组。组1(TS 0-8),组2(TS 9-11)和组3(TS 12-15)。患者的平均年龄为61.5岁,主要原发肿瘤部位如下:肾脏(23%),肺(19%)和乳房(18%)。结果:德桥总体一致性为67.6%。每组的一致性如下:第1组80%,在第2组中,仅观察到33%的一致性。在第3组中,观察到100%的一致性。在第2组中,最常见的原发部位是乳房和肾脏,平均生存期分别为20和22.3个月,均比该组的预期寿命长。结论:德桥的一致性在我们的研究中是可以接受的,特别是在较低和较高的分数中。在第二组中观察到的一致性较低(33.3%),几乎在所有肿瘤中均观察到。就我们的实践而言,TS是定义生存率(尤其是分数较低和较高)的可接受的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号